AirSculpt Technologies, Inc. (AIRS) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.03 per share when it actually produced a loss of $0.02, delivering a surprise of +33.33%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.AirSculpt Technolog ...

[Report Overview and Highlights](index=1&type=section&id=Report%20Overview%20and%20Highlights) [Q2 and First Six Months 2025 Performance Summary](index=1&type=section&id=Q2%20and%20First%20Six%20Months%202025%20Performance%20Summary) AirSculpt Technologies narrowed revenue decline and achieved record lead growth in Q2 and H1 FY2025, launching new services and reducing debt - The company advanced its transformation in a dynamic environment, narrowing the year-over-year revenue decline and achieving **record lead growth** and a significant increase in consultations[4](index=4&type=chunk) - Piloted two new services: skin tightening (addressing GLP-1s-related skin laxity) and expanded consumer financing options to enhance growth strategy[4](index=4&type=chunk) - Successfully reduced **$16 million debt** through a June common stock offering, strengthening the balance sheet[4](index=4&type=chunk) Key Financial Data for Q2 and First Six Months FY2025 | Metric | Q2 2025 | Q2 2024 | Change (YoY) | H1 2025 | H1 2024 | Change (YoY) | | :------------------- | :------- | :------- | :--------- | :----------- | :----------- | :--------- | | **Operating Data:** | | | | | | | | Case Volume | 3,392 | 3,949 | -14.1% | 6,468 | 7,695 | -15.9% | | **Financial Data (Millions USD):** | | | | | | | | Revenue | $44.0 | $51.0 | -13.7% | $83.4 | $98.6 | -15.5% | | Net Loss/Net Income | $(0.6) | $(3.2) | 81.3% | $(3.4) | $2.8 | -221.4% | | Adjusted EBITDA | $5.8 | $6.9 | -15.9% | $9.6 | $14.2 | -32.4% | [2025 Financial Outlook](index=1&type=section&id=2025%20Financial%20Outlook) The company reaffirmed its FY2025 full-year revenue and Adjusted EBITDA guidance, projecting revenue of $160-170 million FY2025 Full-Year Guidance | Metric | FY2025 Full-Year Guidance | | :------------- | :------------------- | | Revenue | Approx. $160 - $170 Million USD | | Adjusted EBITDA | Approx. $16 - $18 Million USD | [Liquidity Position](index=1&type=section&id=Liquidity%20Position) As of June 30, 2025, the company held $8.2 million cash and $5 million revolving credit capacity, meeting bank covenants - As of June 30, 2025, the company held **$8.2 million cash and cash equivalents** and had **$5 million revolving credit facility borrowing capacity**[6](index=6&type=chunk) - Cash flow from operating activities for H1 2025 was **$5.9 million**, lower than $6.8 million in the same period of 2024[6](index=6&type=chunk) - The company met its bank covenant requirements at the end of Q2 FY2025[6](index=6&type=chunk) [CFO Retirement Announcement](index=1&type=section&id=CFO%20Retirement%20Announcement) CFO Dennis Dean's retirement was announced, with CEO Yogi Jashnani acknowledging his pivotal role in financial framework and capital market activities - Dennis Dean plans to retire from the **Chief Financial Officer position**, remaining until a permanent successor is in place[3](index=3&type=chunk)[8](index=8&type=chunk) - CEO Yogi Jashnani acknowledged Dennis Dean's **important contributions** in implementing financial frameworks, leading a successful IPO, and recent common stock offering[8](index=8&type=chunk) [Company Information](index=2&type=section&id=Company%20Information) [About AirSculpt Technologies](index=2&type=section&id=About%20AirSculpt%20Technologies) AirSculpt offers next-generation body contouring treatments focused on comfort and precision, exclusively available in AirSculpt offices for minimal invasiveness and rapid recovery - AirSculpt offers **next-generation body contouring treatment**, focusing on comfort and precision, exclusively available in AirSculpt offices[11](index=11&type=chunk) - This minimally invasive procedure aims to remove fat, tighten skin, and sculpt target areas for **rapid healing, minimal bruising, and precise results**[11](index=11&type=chunk) [Investor Relations Information](index=2&type=section&id=Investor%20Relations%20Information) The company will host a conference call on August 1, 2025, with webcast access and replay, providing investor information via its website and ICR, Inc - The company will hold a **August 1, 2025 conference call**, offering dial-in and webcast access, with webcast replay available for approximately 90 days[9](index=9&type=chunk) - AirSculpt publishes **important company information** via its investor relations website (https://investors.airsculpt.com)[10](index=10&type=chunk) - Investors can contact **Allison Malkin of ICR, Inc.** for investor information[35](index=35&type=chunk) [Detailed Financial Results (GAAP)](index=4&type=section&id=Detailed%20Financial%20Results%20(GAAP)) [Consolidated Statements of Operations](index=4&type=section&id=Consolidated%20Statements%20of%20Operations) In Q2 FY2025, revenue declined 13.7% to $44.01 million, with net loss narrowing to $0.59 million; H1 revenue decreased 15.5% to $83.38 million, resulting in a $3.44 million net loss Consolidated Statements of Operations Summary (Thousands USD) | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :-------------------------- | :------- | :------- | :----------- | :----------- | | Revenue | $44,012 | $51,004 | $83,383 | $98,624 | | Selling, General and Administrative Expenses | $22,671 | $34,274 | $44,439 | $50,030 | | Operating Income/(Loss) | $786 | $(4,981) | $(803) | $6,031 | | Net Loss/(Income) | $(591) | $(3,206) | $(3,438) | $2,823 | | Basic Loss/(Income) Per Share (USD) | $(0.01) | $(0.06) | $(0.06) | $0.05 | | Diluted Loss/(Income) Per Share (USD) | $(0.01) | $(0.06) | $(0.06) | $0.05 | [Consolidated Balance Sheet Data](index=5&type=section&id=Consolidated%20Balance%20Sheet%20Data) As of June 30, 2025, cash and equivalents stood at $8.19 million, total assets at $198.37 million, with total liabilities decreasing to $107.21 million and equity rising to $91.16 million Consolidated Balance Sheet Data Summary (Thousands USD) | Metric | June 30, 2025 | December 31, 2024 | | :-------------------- | :------------- | :--------------- | | Cash and Cash Equivalents | $8,189 | $8,235 | | Total Assets | $198,367 | $209,996 | | Long-Term Debt, Net | $53,188 | $65,456 | | Total Liabilities | $107,210 | $130,706 | | Total Stockholders' Equity | $91,157 | $79,290 | [Consolidated Cash Flow Data](index=5&type=section&id=Consolidated%20Cash%20Flow%20Data) Q2 FY2025 saw $4.98 million in operating cash flow, $0.27 million in investing outflow, and $2.08 million in financing outflow; H1 operating cash flow was $5.85 million Consolidated Cash Flow Data Summary (Thousands USD) | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :-------------------- | :------- | :------- | :----------- | :----------- | | Net Cash Provided by Operating Activities | $4,984 | $3,442 | $5,852 | $6,807 | | Net Cash Used in Investing Activities | $(265) | $(4,018) | $(2,166) | $(5,580) | | Net Cash Used in Financing Activities | $(2,083) | $(527) | $(3,732) | $(1,623) | [Operational and Supplemental Data](index=5&type=section&id=Operational%20and%20Supplemental%20Data) [Key Operating Metrics](index=5&type=section&id=Key%20Operating%20Metrics) In Q2 FY2025, case volume decreased 14.1% to 3,392, while revenue per case slightly increased to $12,975; facilities expanded to 32 with 67 operating rooms Key Operating Metrics Summary | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :----------------- | :------- | :------- | :----------- | :----------- | | Number of Facilities | 32 | 27 | 32 | 27 | | Total Operating Rooms | 67 | 57 | 67 | 57 | | Case Volume | 3,392 | 3,949 | 6,468 | 7,695 | | Revenue Per Case (USD) | $12,975 | $12,916 | $12,892 | $12,817 | [Same-Center Performance

MIAMI BEACH, Fla., Aug. 01, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2025. The Company also announced that Dennis Dean intends to retire from his position of Chief Financial Officer. Mr. Dean will retain his role until a permanent successor is in place. First Six Months 2025 Results 2025 Outlook The Company is affirming its full ye ...

Company Overview - AirSculpt Technologies, Inc. is an industry leader in premium body contouring procedures, focusing on next-generation treatments that optimize comfort and precision [3]. Financial Results Announcement - AirSculpt will report its second quarter 2025 financial results before the market opens on August 1, 2025, followed by a conference call at 8:30 a.m. Eastern Time on the same day [1]. Conference Call Details - The conference call can be accessed via a toll-free domestic number (1-877-407-9716) or an international number (1-201-493-6779) using the conference ID 13754561, with a live webcast available on the investor relations section of the AirSculpt website [2].

Programming Update - Nickelodeon has added two new animated series, Unicorn Academy and Vida the Vet, to its programming lineup starting July 2025, marking their linear debuts in the U.S. [1] - Unicorn Academy follows the adventures of Sophia and her classmates at a magical boarding school on Unicorn Island, focusing on themes of friendship and rivalry while protecting the island's magic [1]. - Episodes of Unicorn Academy will air on Sundays at 9 a.m. (ET/PT) for four consecutive weeks [1]. - Vida the Vet centers on a 10-year-old girl named Vida who aspires to be a veterinarian, helping animals in her new town of Sweetwood [2]. - Episodes of Vida the Vet will be broadcast Monday-Thursday at 10 a.m. (ET/PT) throughout July [2]. Company Overview - Spin Master Corp. is a leading global children's entertainment company known for creating engaging play experiences across toys, entertainment, and digital games [3]. - The company is recognized for its award-winning brands such as PAW Patrol, Melissa & Doug, Bakugan, and Rubik's Cube, and has a strong presence in digital games with 70 million active users monthly [3]. - Spin Master operates 29 offices in nearly 20 countries and employs over 2,500 team members globally [3]. Nickelodeon Brand - Nickelodeon, now in its 46th year, is the leading entertainment brand for kids, focusing on diverse programming and consumer products [4]. - The brand encompasses television programming, digital experiences, publishing, and feature films, and is part of Paramount's global portfolio of multimedia entertainment brands [4].

Company Overview - AirSculpt Technologies, Inc. (AIRS) shares increased by 8.7% to $5.25 in the last trading session, supported by higher-than-average trading volume [1] - The stock has gained 8.3% over the past four weeks, driven by stronger profitability and early success from its go-to-market strategy [1] Earnings Expectations - The company is projected to report quarterly earnings of $0.02 per share, reflecting a year-over-year decline of 77.8% [2] - Expected revenues are $45.64 million, which is a decrease of 10.5% compared to the same quarter last year [2] Earnings Estimate Revisions - The consensus EPS estimate for AirSculpt Technologies has been revised 100% higher in the last 30 days, indicating a positive trend that may lead to price appreciation [3] - A strong correlation exists between earnings estimate revisions and near-term stock price movements, suggesting potential for further strength in AIRS [3] Industry Comparison - AirSculpt Technologies is classified under the Zacks Technology Services industry, which includes other companies like Ibotta (IBTA) [4] - Ibotta's consensus EPS estimate has remained unchanged at $0.18, representing a year-over-year increase of 113.6% [5] - Ibotta has a Zacks Rank of 3 (Hold), while AirSculpt Technologies holds a Zacks Rank of 2 (Buy) [4][5]

Core Viewpoint - AirSculpt Technologies, Inc. has successfully completed a common stock offering, generating net proceeds of approximately $13.8 million, which will be used to prepay $10 million of its outstanding term loan debt, enhancing its capital structure and financial flexibility [1][2]. Financial Performance - The company has prepaid $10 million of its outstanding debt, improving its capital structure [1][2]. - After the stock offering, AirSculpt has 62,436,670 shares of common stock outstanding [2]. - The company retains full availability of $5 million under its revolving credit facility after making a remaining payment of $2.9 million on June 16, 2025 [2]. Strategic Initiatives - The prepayment of debt is part of the company's strategy to advance its transformation and position itself for sustained long-term growth in revenue and profitability [2]. - The company does not anticipate the need for additional material capital raises this year, assuming no significant changes in the macroeconomic environment [1]. Product Offering - AirSculpt provides a next-generation body contouring treatment that is minimally invasive, designed to optimize comfort and precision, allowing for quick healing with minimal bruising and precise results [3].

Core Viewpoint - AirSculpt Technologies, Inc. has successfully closed a public offering of 3,160,000 shares of common stock, with an additional 474,000 shares purchased by the underwriter, resulting in estimated proceeds of approximately $13.8 million after expenses [1][2]. Group 1: Offering Details - The public offering was underwritten by Leerink Partners, who acted as the sole bookrunner [2]. - The majority of the net proceeds from the offering will be used for prepaying a portion of the Company's outstanding debt under its existing credit agreement, while the remainder will be allocated for general corporate purposes, including working capital and other business opportunities [2]. Group 2: Regulatory Information - A shelf registration statement for the shares was filed with the Securities and Exchange Commission (SEC) and became effective on March 24, 2025 [3]. - A final prospectus supplement and accompanying prospectus related to the offering have been filed with the SEC and are accessible on the SEC's website [3]. Group 3: Company Overview - AirSculpt is a provider of next-generation body contouring treatments, focusing on comfort and precision, with procedures designed to remove fat and tighten skin while allowing for quick healing and minimal bruising [5].

Core Viewpoint - AirSculpt Technologies, Inc. has announced a public offering of 3,160,000 shares of common stock priced at $3.80 per share, aiming to raise $12.0 million before expenses [1][2]. Group 1: Offering Details - The company has granted the underwriter a 30-day option to purchase up to 474,000 additional shares at the same price [1]. - The offering is expected to close on or about June 11, 2025, subject to customary closing conditions [1]. Group 2: Use of Proceeds - A majority of the net proceeds from the offering will be used for the prepayment of a portion of the company's outstanding indebtedness under its existing credit agreement [2]. - The remainder of the net proceeds will be allocated for general corporate purposes, including working capital and other business opportunities [2]. Group 3: Company Overview - AirSculpt is a provider of next-generation body contouring treatments designed for comfort and precision, focusing on minimally invasive procedures that remove fat and tighten skin [5].

Core Viewpoint - AirSculpt Technologies, Inc. has announced a public offering of 3,160,000 shares of its common stock, with an additional option for underwriters to purchase up to 474,000 shares [1][2]. Group 1: Offering Details - The public offering consists of 3,160,000 shares of common stock, with a 30-day option for underwriters to buy an additional 474,000 shares [1]. - Vesey Street Capital Partners, the largest stockholder, is interested in purchasing up to $4.0 million in shares from the offering [2]. - Leerink Partners is acting as the sole bookrunner for the offering [3]. Group 2: Use of Proceeds - A portion of the net proceeds from the offering will be used to prepay part of the Company's outstanding debt under its existing credit agreement [3]. - The remaining proceeds will be allocated for general corporate purposes, including working capital and other business opportunities [3]. Group 3: Regulatory Information - A shelf registration statement for the shares was filed with the Securities and Exchange Commission and became effective on March 24, 2025 [4].